Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

Presentation TCT 2022

Anticoagulation Strategies in High-Risk PE: Are DOACs Enough? When Do We Switch?

Presenter: Teresa Carman

September 19, 2022

Presentation TCT 2021

What About Anticoagulation Alone?

Presenter: Teresa Carman

November 06, 2021

Presentation TCT 2021

Oral Anticoagulation Should Be the Default Strategy After LAAC

Presenter: Matthew J. Price

November 06, 2021

Presentation TCT 2021

Medical Therapy for PAD: PCSK9, SGLT2, Anticoagulation and Beyond

Presenter: Connie Hess

November 06, 2021

Presentation Controversies and Advances 2019

Left Atrial Appendage Occlusion: A Valid Option to Anticoagulation for Stroke Prevention

Presenter: Tarun Chakravarty

November 15, 2019

Presentation LINC 2019

What Are the Current Recommendations for “Optimal Medical Therapy”

Presenter: Daniella Kadian-Dodov

January 25, 2019

Presentation TCT 2018

Choice and Duration of Antiplatelet and Anticoagulation Therapy After Venous Interventions (With Case Reviews)

Presenter: Brian G. DeRubertis, Mahmood K. Razavi, Anthony J. Comerota

September 24, 2018

Presentation TCT 2017

TCT 92: Polyvascular Disease and Risk of Major Cardiovascular Events in Peripheral Artery Disease - Insights From EUCLID

Presenter: Kurt Huber, Jamil Abdalla Saad, Antonio Gutierrez, MD

October 31, 2017

Presentation TCT 2017

Anticoagulation Following DVT/PE Intervention: What, When, Why, and for How Long?

Presenter: Michael R. Jaff, Robert A. Lookstein, Teresa L. Carman

October 30, 2017

Presentation ISET 2017

Anticoagulation Following DVT: Agents and Length of Treatment

Presenter: Ian del Conde

February 04, 2017

Advertisement

Anticoagulation Strategies in High-Risk PE: Are DOACs Enough? When Do We Switch?

What About Anticoagulation Alone?

Oral Anticoagulation Should Be the Default Strategy After LAAC

Medical Therapy for PAD: PCSK9, SGLT2, Anticoagulation and Beyond

Left Atrial Appendage Occlusion: A Valid Option to Anticoagulation for Stroke Prevention

What Are the Current Recommendations for “Optimal Medical Therapy”

Choice and Duration of Antiplatelet and Anticoagulation Therapy After Venous Interventions (With Case Reviews)

TCT 92: Polyvascular Disease and Risk of Major Cardiovascular Events in Peripheral Artery Disease - Insights From EUCLID

Anticoagulation Following DVT/PE Intervention: What, When, Why, and for How Long?

Anticoagulation Following DVT: Agents and Length of Treatment

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content